Doğruel, H. Et Al. 2023. Comparative evaluation of clinical outcomes of dapagliflozin and empagliflozin in type-2 diabetes mellitus.. Irish journal of medical science , vol.192, no.5 , 2189-2195.

Doğruel, H., Atlım, H. T., Aydemir, M., Yılmaz, N., & Sarı, R., (2023). Comparative evaluation of clinical outcomes of dapagliflozin and empagliflozin in type-2 diabetes mellitus.. Irish journal of medical science , vol.192, no.5, 2189-2195.

Doğruel, Hakan Et Al. "Comparative evaluation of clinical outcomes of dapagliflozin and empagliflozin in type-2 diabetes mellitus.," Irish journal of medical science , vol.192, no.5, 2189-2195, 2023

Doğruel, Hakan Et Al. "Comparative evaluation of clinical outcomes of dapagliflozin and empagliflozin in type-2 diabetes mellitus.." Irish journal of medical science , vol.192, no.5, pp.2189-2195, 2023

Doğruel, H. Et Al. (2023) . "Comparative evaluation of clinical outcomes of dapagliflozin and empagliflozin in type-2 diabetes mellitus.." Irish journal of medical science , vol.192, no.5, pp.2189-2195.

@article{article, author={Hakan Doğruel Et Al. }, title={Comparative evaluation of clinical outcomes of dapagliflozin and empagliflozin in type-2 diabetes mellitus.}, journal={Irish journal of medical science}, year=2023, pages={2189-2195} }